Offer - Urjas Oil for just ₹ 1
Golin 0.5 Mg Tablet is a prescription medicine that is available as a Tablet. Acromegaly, Prolactinoma are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Golin 0.5 Mg Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
While these are the most often observed Golin 0.5 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Golin 0.5 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Golin 0.5 Mg Tablet's effect during pregnancy is Mild and Severe while nursing. Further, the section on Golin 0.5 Mg Tablet related warnings talks about Golin 0.5 Mg Tablet's effects on the liver, heart and kidney.
Golin 0.5 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Golin 0.5 Mg Tablet in conditions like High Blood Pressure, Heart Disease, Depression. Other contraindications of Golin 0.5 Mg Tablet have been discussed in the sections ahead.
Additionally, Golin 0.5 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Golin 0.5 Mg Tablet is not safe while driving, and is is not addictive in nature.
Golin 0.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Golin 0.5 Mg Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Golin has mild side effects when taken during pregnany
Is the use of Golin 0.5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Golin. So it is adviced to consult the doctor before using it.
What is the effect of Golin 0.5 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Golin. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Golin 0.5 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Golin. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Golin 0.5 Mg Tablet on the Heart?
There may be an adverse effect on the heart after taking Golin. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Golin 0.5 Mg Tablet unless your doctor advises you to do so -
Is this Golin 0.5 Mg Tablet habit forming or addictive?
Forming a habit of Golin 0.5 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Golin 0.5 Mg Tablet, you should not drive or work on any heavy machine, as Golin 0.5 Mg Tablet can make you drowsy.
Is it safe?
Golin 0.5 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Golin 0.5 Mg Tablet for mental disorders.
Interaction between Food and Golin 0.5 Mg Tablet
Due to the absence of research, it is difficult to say how Golin 0.5 Mg Tablet and food will interact.
Interaction between Alcohol and Golin 0.5 Mg Tablet
Taking Golin 0.5 Mg Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)
